Drug class
Intravenous ferric gluconate–carbohydrate complex; parenteral iron replacement agent
Mechanism of action
A colloidal ferric iron-carbohydrate complex that is taken up by reticuloendothelial cells after intravenous administration, releasing iron for transferrin binding and haemoglobin synthesis. It is an intact complex rather than a simple sodium or gluconate salt.
General use cases
- Treatment of iron-deficiency anaemia in adults and paediatric patients with chronic kidney disease receiving haemodialysis and supplemental epoetin therapy under the US FERRLECIT indication; not interchangeable with oral iron salts
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
